mTOR regulates memory CD8 T-cell differentiation (original) (raw)

Nature volume 460, pages 108–112 (2009)Cite this article

Abstract

Memory CD8 T cells are a critical component of protective immunity, and inducing effective memory T-cell responses is a major goal of vaccines against chronic infections and tumours1,2,3. Considerable effort has gone into designing vaccine regimens that will increase the magnitude of the memory response, but there has been minimal emphasis on developing strategies to improve the functional qualities of memory T cells4. Here we show that mTOR (mammalian target of rapamycin5, also known as FRAP1) is a major regulator of memory CD8 T-cell differentiation, and in contrast to what we expected, the immunosuppressive drug rapamycin has immunostimulatory effects on the generation of memory CD8 T cells. Treatment of mice with rapamycin following acute lymphocytic choriomeningitis virus infection enhanced not only the quantity but also the quality of virus-specific CD8 T cells. Similar effects were seen after immunization of mice with a vaccine based on non-replicating virus-like particles. In addition, rapamycin treatment also enhanced memory T-cell responses in non-human primates following vaccination with modified vaccinia virus Ankara. Rapamycin was effective during both the expansion and contraction phases of the T-cell response; during the expansion phase it increased the number of memory precursors, and during the contraction phase (effector to memory transition) it accelerated the memory T-cell differentiation program. Experiments using RNA interference to inhibit expression of mTOR, raptor (also known as 4932417H02Rik) or FKBP12 (also known as FKBP1A) in antigen-specific CD8 T cells showed that mTOR acts intrinsically through the mTORC1 (mTOR complex 1) pathway to regulate memory T-cell differentiation. Thus these studies identify a molecular pathway regulating memory formation and provide an effective strategy for improving the functional qualities of vaccine- or infection-induced memory T cells.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Williams, M. A. & Bevan, M. J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171–192 (2007)
    Article CAS Google Scholar
  2. Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848–862 (2008)
    Article CAS Google Scholar
  3. Klebanoff, C. A., Gattinoni, L. & Restifo, N. P. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol. Rev. 211, 214–224 (2006)
    Article CAS Google Scholar
  4. Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: implications for vaccine design. Nature Rev. Immunol. 8, 247–258 (2008)
    Article CAS Google Scholar
  5. Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006)
    Article CAS Google Scholar
  6. Cao, W. et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nature Immunol. 9, 1157–1164 (2008)
    Article CAS Google Scholar
  7. Sinclair, L. V. et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nature Immunol. 9, 513–521 (2008)
    Article CAS Google Scholar
  8. Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA 105, 7797–7802 (2008)
    Article ADS CAS Google Scholar
  9. Haxhinasto, S., Mathis, D. & Benoist, C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–574 (2008)
    Article CAS Google Scholar
  10. Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunol. 4, 1191–1198 (2003)
    Article CAS Google Scholar
  11. Huster, K. M. et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl Acad. Sci. USA 101, 5610–5615 (2004)
    Article ADS CAS Google Scholar
  12. Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrançois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo . Nature Immunol. 1, 426–432 (2000)
    Article CAS Google Scholar
  13. Tan, J. T. et al. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195, 1523–1532 (2002)
    Article CAS Google Scholar
  14. Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4, 225–234 (2003)
    Article CAS Google Scholar
  15. Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625–640 (2008)
    Article CAS Google Scholar
  16. Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281–295 (2007)
    Article CAS Google Scholar
  17. Grayson, J. M., Zajac, A. J., Altman, J. D. & Ahmed, R. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164, 3950–3954 (2000)
    Article CAS Google Scholar
  18. Storni, T. et al. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 172, 1777–1785 (2004)
    Article CAS Google Scholar
  19. Ohtani, M. et al. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112, 635–643 (2008)
    Article CAS Google Scholar
  20. Weichhart, T. et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565–577 (2008)
    Article CAS Google Scholar
  21. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177–189 (2002)
    Article CAS Google Scholar
  22. Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163–175 (2002)
    Article CAS Google Scholar
  23. Kaech, S. M. & Wherry, E. J. Heterogeneity and cell-fate decisions in effector and memory CD8(+) T cell differentiation during viral infection. Immunity 27, 393–405 (2007)
    Article CAS Google Scholar
  24. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998)
    Article CAS Google Scholar

Download references

Acknowledgements

We thank B. T. Konieczny for technical assistance; D. Garber for providing us with the MVA; R. Amara for help developing rhesus macaque assays; W. Hahn for providing pMKO.1 GFP vector; and E. Strobert and P. L. Turner for technical assistance. This work was supported by NIH grants AI030048 (to R.A.) and N01-AI-50025 and AI040519 (to C.P.L).

Author Contributions K.A. and R.A. designed mouse experiments; A.P.T., V.O.S., S.G. and C.P.L designed macaque experiments; K.A. performed mouse experiments; A.P.T., V.O.S. and S.G. performed macaque experiments; K.A. and R.A. analysed mouse data; K.A., A.P.T., V.O.S., S.G. and C.P.L analysed macaque data; S.A.K. and M.F.B. provided critical reagents; and K.A. and R.A. wrote the paper.

Author information

Authors and Affiliations

  1. Emory Vaccine Center and Department of Microbiology and Immunology,,
    Koichi Araki & Rafi Ahmed
  2. Emory Transplant Center and Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA,
    Alexandra P. Turner, Virginia Oliva Shaffer, Shivaprakash Gangappa & Christian P. Larsen
  3. Cytos Biotechnology AG, Wagistrasse 25, 8952 Zürich-Schlieren, Switzerland ,
    Susanne A. Keller & Martin F. Bachmann

Authors

  1. Koichi Araki
    You can also search for this author inPubMed Google Scholar
  2. Alexandra P. Turner
    You can also search for this author inPubMed Google Scholar
  3. Virginia Oliva Shaffer
    You can also search for this author inPubMed Google Scholar
  4. Shivaprakash Gangappa
    You can also search for this author inPubMed Google Scholar
  5. Susanne A. Keller
    You can also search for this author inPubMed Google Scholar
  6. Martin F. Bachmann
    You can also search for this author inPubMed Google Scholar
  7. Christian P. Larsen
    You can also search for this author inPubMed Google Scholar
  8. Rafi Ahmed
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toRafi Ahmed.

Supplementary information

PowerPoint slides

Rights and permissions

About this article

Cite this article

Araki, K., Turner, A., Shaffer, V. et al. mTOR regulates memory CD8 T-cell differentiation.Nature 460, 108–112 (2009). https://doi.org/10.1038/nature08155

Download citation

This article is cited by

Editorial Summary

T-cell memory regulation by mTOR

mTOR, part of the PI3K–AKT–mTOR cell-signalling cascade and a target for the antitumour drug rapamycin, is identified here as a regulator of CD8 T-cell differentiation. Despite its primarily immunosuppressive activity, rapamycin can enhance immune responses to experimental vaccines in mice and monkeys. This counterintuitive finding points to the ability to increase the functional qualities of memory T cells as a potential way of enhancing the efficacy of vaccines against pathogens and cancers.

Associated content